1952-1953 — Page 26

Kowloon-Canton Railway Departmental Reports 九廣鐵路年報 All

$

Balance at close of year

Increase

Decrease

Balance at beginning of

Heads of classification

Balance at close of year

Increase

Decrease

year

Asset or Debit Balance

B-6 Investment

Assets:

36,070,356.20|B-6-1 Cost of Road

& Equipment

37,881,310.30

1,810,954.10)

B-1 Capita Liabilit-

ies :

B-1-1 Railway

Investment

36,070,356.20 B-1-3 Perm. Govt.

36,070,356.20 Total Investment

Investment

8.880,000.00)

29,250,750.15

8,880,000.00|

6,819,606.05

Assets

37,881,310.30

1,810,954.10

36,070,356.20] Total Capital Liabi-

lities

B-7 Working Assets:-|

38,130.750.15] 8,880,000.00 6,819,606.05

10,352.33 B-7-1-1 Cash

19,507.31

9,154.98

23,010.75 B-7-4-2 Sundry

Debtors

23,010.75

B-2 Working Liabi- lities:

23,891.00! B-7-4-3 Advance

Account

615,742.99 B-7-5 Stores

4,995.44 B-7-5-1 Workshop

Suspense

677,992.51 Total Working Assets

D-8 Deferred Debit

17,619.00

549,012.79|

6,272.00

66,730.20

85,306.61| B-2-2 Traffic Balance

Payable (Foreign

Railway)

31,261.62

54,044.99

2,054.49|

2,940.957

23,010.75| B-2-4-2 Sundry

Creditors

23,010.75

588,193.59]

9,154.98

98,953.90

108,317.36 Total Working Liabi- lities

31,261,62

77,055.74

Balance at beginning of

year

Heads of classification

21

Items :-

9,120,159.11|D-8-1 Temporary

B-3 Deferred Credit] Items :-

Advances to Government

4,669,022.72

4,451,136.39

1,214,796.89 B-3-3 Depreciation

Reserves

1,645,236.09

430,439.20

15,932.48 B-3-5 Misc. Deferred

9,120,159.11

4,669,022.72

4,451,136.39

Credits

27,727.45

1,230,729.37

1,672,963,54

11,794.97|

442,234.17

B-9 Balance of accumulated

Deficit

8,459,104.89 B-4 Appropriation

45,868,507.82|

43,138,526,61|

1,820,109,08

4,550,090.29] 45,868,507.82

from Surpluses.......... 3,303,551.30)

43,138,526.61| 9,322,234,17| 12,052,215.38

5,155,553.59

Comments

Approved members can add comments, bookmarks, and private notes.

No comments yet.

Private Research Note

Private notes are available after approval.